The Ensign Group, Inc. ENSG is aided by improved service revenues, energetic pursuit of acquisitions and a robust monetary place. Straight dividend hikes for 23 years additionally reinforce traders’ confidence within the inventory.
Zacks Rank & Value Efficiency
Ensign Group carries a Zacks Rank #3 (Maintain) at current.
The inventory has gained 31.9% previously yr in contrast with the trade’s 29.3% progress. The Medical sector and the S&P 500 composite index have elevated 5.6% and 18.2%, respectively, in the identical time-frame.
Picture Supply: Zacks Funding Analysis
Favorable Model Rating
ENSG is well-poised for progress, as evidenced by its spectacular VGM Rating of A. Right here, V stands for Worth, G for Development and M for Momentum, and the rating is a weighted mixture of all three elements.
Sturdy Development Prospects
The Zacks Consensus Estimate for Ensign Group’s 2025 earnings is pegged at $6.50 per share, indicating an enchancment of 18.2% from the year-earlier studying, whereas the identical for revenues is $5.1 billion, implying a 18.9% enhance from the prior-year precise.
The consensus mark for 2026 earnings is pegged at $7.09 per share, indicating 9% progress from the 2025 estimate. The identical for revenues stands at $5.6 billion, which signifies an increase of 11.3% from the 2025 estimate.
Spectacular Shock Historical past
ENSG’s earnings outpaced estimates in every of the trailing 4 quarters, the common shock being 2.27%.
Strong Return on Fairness
Ensign Group’s effectivity in using shareholders’ funds might be substantiated by its return on fairness of 18.5%, towards the trade’s unfavorable return of 17.7%.
Key Enterprise Tailwinds
Ensign Group’s income enlargement is primarily pushed by growing service revenues, stemming from its superior healthcare choices throughout expert nursing, rehabilitation, and senior dwelling services. The growing old U.S. inhabitants continues to gasoline robust demand for senior care providers, positioning Ensign favorably in the long run. Moreover, the growing requirement for efficient rehabilitation—serving to people regain day by day performance—is anticipated to considerably contribute to the income progress of its Expert Providers section.
The corporate’s Commonplace Bearer section additionally performs a pivotal function in its monetary efficiency. This division generates constant rental revenue by leasing post-acute care properties—owned by Ensign—to healthcare operators underneath triple-net lease agreements. These leases not solely present a steady income stream but additionally shift property-related prices to tenants, thereby enhancing operational effectivity.
Ensign’s aggressive acquisition technique additional strengthens its progress trajectory. The corporate actively acquires services in numerous areas throughout the US, selling collaboration with native care groups. This localized method permits Ensign to raised tackle particular regional healthcare wants and provide high-quality care to underserved communities.
In December 2025, Ensign acquired the operations of 4 expert nursing services in Colorado, Kansas and Arizona. These strategic acquisitions improve Ensign’s healthcare portfolio and nationwide footprint. Presently, Ensign operates 373 healthcare services throughout 17 states and owns 156 actual property property, with acquisitions remaining a core focus of its capital allocation technique.
To help this progress and ongoing investments, a robust monetary basis stays important. Ensign advantages from wholesome money reserves and sturdy money movement era, enabling continued funding in strategic initiatives. These monetary strengths additionally empower the corporate to ship shareholder worth by means of share repurchases and dividend funds. Notably, Ensign has elevated its dividend for 23 consecutive years, with the latest hike being 4%.
ENSG’s Key Dangers
The corporate continues to expertise a sustained enhance in bills, which rose 18.3% yr over yr throughout the first 9 months of 2025. This upward development in prices presents a rising risk to revenue margins, particularly as operational utilization rises and labor market instability persists. Moreover, ongoing unfavorable free money movement and escalating competitors from rising market gamers might add extra strain to the corporate’s total monetary efficiency.
Shares to Take into account
Some better-ranked shares within the Medical house are Collegium Pharmaceutical, Inc. COLL, Addus HomeCare Company ADUS and Intuitive Surgical, Inc. ISRG. Whereas Collegium Pharmaceutical sports activities a Zacks Rank #1 (Sturdy Purchase), Addus HomeCare and Intuitive Surgical carry a Zacks Rank #2 (Purchase) every at current. You may see the whole record of immediately’s Zacks #1 Rank shares right here.
Collegium Pharmaceutical’s earnings surpassed estimates in every of the final 4 quarters, the common shock being 10.63%. The Zacks Consensus Estimate for COLL’s 2025 earnings signifies a 17.1% rise, whereas the identical for revenues implies an enchancment of 24.2% from the respective prior-year figures. The consensus mark for COLL’s earnings has moved 6.6% north previously 60 days.
The underside line of Addus HomeCare outpaced estimates in three of the trailing 4 quarters and matched the mark as soon as, the common shock being 2.87%. The Zacks Consensus Estimate for ADUS’ 2025 earnings signifies a 17.7% rise, whereas the identical for revenues implies an enchancment of twenty-two.9% from the respective prior-year figures. The consensus mark for ADUS’ earnings has moved 0.7% north previously 60 days.
Intuitive Surgical’s earnings outpaced estimates in every of the trailing 4 quarters, the common shock being 16.34%. The Zacks Consensus Estimate for ISRG’s 2025 earnings signifies a 17.9% rise, whereas the identical for revenues implies an enchancment of 18.7% from the respective prior-year tallies. The consensus mark for ISRG’s earnings has moved up 0.5% previously 30 days.
Shares of Collegium Pharmaceutical and Intuitive Surgical have gained 70.8% and eight%, respectively, previously yr. Nevertheless, Addus HomeCare inventory declined 13.8% in the identical time-frame.
Zacks Naming High 10 Shares for 2026
Need to be tipped off early to our 10 high picks for the whole lot of 2026? Historical past suggests their efficiency might be sensational.
From 2012 (when our Director of Analysis Sheraz Mian assumed duty for the portfolio) by means of November, 2025, the Zacks High 10 Shares gained +2,530.8%, greater than QUADRUPLING the S&P 500’s +570.3%.
Now Sheraz is combing by means of 4,400 firms to handpick one of the best 10 tickers to purchase and maintain in 2026. Don’t miss your likelihood to get in on these shares after they’re launched on January 5.
Be First to New High 10 Shares >>
Intuitive Surgical, Inc. (ISRG) : Free Inventory Evaluation Report
Addus HomeCare Company (ADUS) : Free Inventory Evaluation Report
The Ensign Group, Inc. (ENSG) : Free Inventory Evaluation Report
Collegium Pharmaceutical, Inc. (COLL) : Free Inventory Evaluation Report
This text initially revealed on Zacks Funding Analysis (zacks.com).
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.
